Antibody Suite Covalab specializes in design and development of diverse antibodies (polyclonal, monoclonal, scFv, Fab, VHH, recombinant) and offers purified and labeled antibodies, enabling a broad portfolio for diagnostic, research, and therapeutic applications.

CAR-T Opportunity Recent news indicates Covalab is developing full-length antibodies and fragments for CAR-T cell applications, presenting a potential sales angle for CAR-T research collaborations, sourcing of antibody fragments, and related diagnostics/therapeutics.

Diagnostics Focus Proven track record in diagnostic kit development across biomedicine and agro-food, including autoimmune disease detection and toxin/pesticide assays, suggesting strong demand for ready-to-use kits, validated reagents, and customization for new targets.

Funding Momentum Recent funding support for BioDiaThera projects signals growth and investment in innovative antibody and recombinant protein solutions, presenting an opening to align with Covalab on funded R&D programs and joint development opportunities.

Global Distribution As a supplier to multiple distributors with a wide product range, Covalab offers partnership potential for distribution agreements, white-labeling, and accelerated market reach in biotech labs, pharmaceutical R&D, and academic institutions.